Commodore Capital »

Inflarx Nv shares owned by Commodore Capital

Quarter-by-quarter ownership of Inflarx Nv (IFRX) shares owned by Commodore Capital from 13F filings

Historical chart of Commodore Capital investment in Inflarx Nv

Tip: Access up to 7 years of quarterly data

All positions including Inflarx Nv held by Commodore Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inflarx Nv by Commodore Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $16M 7.3M 2.24

More positions owned by Commodore Capital

Relay Therapeutics (RLAY)
Enliven Therapeutics (ELVN)
Alkermes SHS (ALKS)
Cogent Biosciences (COGT)
Amylyx Pharmaceuticals (AMLX)
Definium Therapeutics Com Shs (DFTX)
Spyre Therapeutics Com New (SYRE)
Alto Neuroscience Com Shs (ANRO)
Tango Therapeutics (TNGX)
Eyepoint Com New (EYPT)
Tyra Biosciences (TYRA)
Damora Therapeutics Com New (DMRA)
Celldex Therapeutics Com New (CLDX)
Pharvaris N V (PHVS)
Lb Pharmaceuticals Com Shs (LBRX)

View all positions for Commodore Capital

Top funds holding Inflarx Nv

Suvretta Capital Management
TCG Crossover Management
FMR
Commodore Capital
Spruce Street Capital
683 Capital Management
Farallon Capital Management
Stempoint Capital
Dr. Jeffrey R. Jay, M.D.
ADAR1 Capital Management
Kalehua Capital Management
Ameriprise Financial
Woodline Partners
Squadron Capital Management
Eversept Partners

View all funds holding Inflarx Nv